We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Savient Sues More Generic Cos. Over Weight-Gain Drug

Law360 (December 4, 2006, 12:00 AM EST) -- Drug manufacturer Savient Pharmaceuticals Inc. has launched a patent infringement suit against Novartis AG unit Sandoz Pharmaceuticals and Upsher-Smith Laboratories Inc. over their generic version of Savient’s lucrative weight-gain drug, Oxandrin....
To view the full article, register now.